Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ICU-SLEEP: Dexmedetomidine for Sleep and Delirium in ICU
NCT03355053Phase 2Completed
- Sponsor
- Massachusetts General Hospital
- Start
- May 2018
- Primary completion
- Apr 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of dexmedetomidine in delirium, sleep deprivation, sponsored by Massachusetts General Hospital. Started May 2018; status: completed.
02
Drugs
dexmedetomidine
03
Conditions
deliriumsleep deprivation
Beyond the preview
Go deeper on NCT03355053.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03355053.